Skip to main content

Genstruct Closes $6.5 Million Financing Round

NEW YORK, Sept. 8 (GenomeWeb News) - Genstruct, a biological mechanism discovery company, said today that it has raised $6.5 million in a round of Series A financing.

Proceeds of the financing, the Cambridge, Mass.-based company said, will be used to expand its technical and business teams, build intellectual property around the company's enabling technology, and conduct internal discovery programs.

The financing was led by A. M. Pappas and Associates, which has placed managing partner Art Pappas on Genstruct's board, and Flagship Ventures.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.